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Brucellosis, a bacterial disease caused by members of the ge-
nus Brucella, remains one of the most common zoonotic dis-
eases worldwide (1-3). The disease occurs in both animals and 
humans,  except  in  those  countries  where  bovine  Brucellosis 
has been eradicated (1). The bacterial pathogen is classified by 
the CDC as a category-B pathogen that has potential for develop-
ment as a bioterrorist agent (1, 4). Brucella spp. is considered to 
be the most common laboratory-acquired pathogen (1, 5). In hu-
mans, Brucellosis behaves as a systemic infection with a very het-
erogeneous clinical spectrum (2, 3, 6). The Brucella organism’s 
predilection for organs rich in reticuloendothelial cells (spleen, 
liver, bone marrow, lymph nodes) and its intracellular location 
are responsible for the chronicity of the disease, which can last 
for months or even years (1, 2, 7). Brucella has been reported to 
compromise the central and peripheral nervous system, as well 
as the gastrointestinal, hepatobiliary, genitourinary, musculo-
skeletal, cardiovascular, and integumentary systems (2). In pa-
tients with Brucellosis, the gastrointestinal system is commonly 
compromised (70%) (5). Because the liver is the largest organ of 
the reticuloendothelial system and plays the important role of 
defense mechanism against Brucella infections, diffuse hepatic 
involvement is usually recorded during the course of human 
Brucellosis infection (8). Brucellosis involves the liver in varying 
ways, including a slight increase in transaminase levels, mild 
hepatosplenomegaly, chronic suppurative disease, and, more 
rarely, acute hepatitis (5, 8-13). In patients infected with Brucella 
melitensis, the involvement of bile canals is observed more of-
ten than other Brucellosis factors (14). Hepatic granulomas are 
often encountered during liver biopsy and can be caused by a 
variety of conditions such as a primary hepatic process, fever of 
unknown origin, or a manifestation of a systemic illness (15, 16). 
Granulomas are reportedly present in 2 to 10% of all liver-biopsy 
specimens examined in general practice (17). Liver Brucelloma, 
or  pseudotumoral  necrotizing  granuloma,  is  an  uncommon 
type of hepatic manifestation by Brucella and is observed in 
only 1.7% of patients affected by Brucellosis (8). Hepatic Brucel-
loma is rarely the first to manifest itself clinically, and a focal 
suppurative lesion may occur if acute Brucellosis is undetected 
or undertreated in the patient (18). Granulomas are aggregates 
of macrophages, often admixed with other inflammatory cells, 
which usually result from a chronic presence of antigens. Gran-
ulomas are a unique inflammatory response that may be idio-
pathic or may be a response to a bacterial, fungal, viral, or para-
sitic infection, in the latter cases representing a manifestation 
of underlying malignancy (15, 17).The pathology report on Bru-
celloma usually shows necrotizing granulomas with a periph-
eral halo of epithelioid cells. lymphocytes, and plasma cells, as 
well as and a polimorphonuclear infiltrate in the necrotic area 
(19-21). Brucellosis involving Brucella abortus is the most com-
mon species that can cause hepatic granulomas that are indis-
tinguishable from sarcoidosis (13, 16), and Brucella abortus is 
the most common species that can cause hepatic granulomas. 
Histopathologically, histiocytic granulomas are present, often 
with  central  necrosis,  portal  and  peripheral  infiltration,  and 
hyperplasia of the Kupffer cells. (11, 22, 23). These granulomas re-
sult from the caseation of a granulomatous reaction by persis-
tent Brucellae within macrophages. At present, approximately 
thirty cases of granulomatous hepatitis (hepatic Brucelloma) 
have been reported in the literature (19, 23, 24). The clinical and 
biochemical abnormalities return to normal after appropriate 
treatment (25). Diagnosis is based on the association of imaging 
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  Implication for Health policy/practice/research/medical education:
This editorial has been written to aware about the drawbacks of the liver 
granuloma and the importance of brucellosis as one of the most com-
mon zoonotic diseases. Reading this article is recommended especially 
to pathologists, infectious diseases specialists and gastroenterologists 
in the viewpoint of differential diagnosis of liver granuloma. Prevention 
of this infection should be considered more by authorized people in the 
health system.
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